Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Goodwill & Intangibles: 2021-2025

Historic Goodwill & Intangibles for AC Immune (ACIU) over the last 4 years, with Sep 2025 value amounting to $63.0 million.

  • AC Immune's Goodwill & Intangibles rose 8.31% to $63.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $63.0 million, marking a year-over-year increase of 8.31%. This contributed to the annual value of $63.0 million for FY2025, which is N/A change from last year.
  • According to the latest figures from Q3 2025, AC Immune's Goodwill & Intangibles is $63.0 million, which was up 103,392.37% from $60,897 recorded in Q2 2025.
  • Over the past 5 years, AC Immune's Goodwill & Intangibles peaked at $63.0 million during Q3 2025, and registered a low of $57,551 during Q4 2024.
  • Over the past 3 years, AC Immune's median Goodwill & Intangibles value was $56.1 million (recorded in 2025), while the average stood at $46.9 million.
  • As far as peak fluctuations go, AC Immune's Goodwill & Intangibles increased by 9.34% in 2023, and later tumbled by 99.90% in 2024.
  • Quarterly analysis of 5 years shows AC Immune's Goodwill & Intangibles stood at $54.7 million in 2021, then dropped by 4.29% to $52.3 million in 2022, then rose by 8.61% to $56.8 million in 2023, then plummeted by 99.90% to $57,551 in 2024, then climbed by 8.31% to $63.0 million in 2025.
  • Its Goodwill & Intangibles was $63.0 million in Q3 2025, compared to $60,897 in Q2 2025 and $56.1 million in Q1 2025.